Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809764 | 0.81 | ALDH1A1 (0.46) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL11127929 | 0.81 | MAPK1 (0.44) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL4462028 | 0.76 | MAPK1 (0.44) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| Tert-Butylbenzene SCHEMBL28991386 | 0.76 | MAPK1 (0.44) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL9576890 | 0.76 | MAPK1 (0.62) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL7129049 | 0.76 | MAPK1 (0.55) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL4448587 | 0.75 | MAPK1 (0.43) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL4462379 | 0.75 | MAPK1 (0.43) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL14690531 | 0.74 | KIF11 (0.43) | MAPK1ALDH1A1ALOX15TAAR1ESR1 | |
| SCHEMBL664301 | 0.74 | MAPK1 (0.52) | MAPK1ALDH1A1ALOX15TAAR1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119406454-A | Phosphorus-containing porous organic polymer supported nickel catalyst and preparation method thereof | 兰州大学 | 2025-02-11 | — | — | CN | disclosed |
| US-12043721-B2 | Antiviral/antimicrobial polymer compositions, fibers, and products | ASCEND PERFORMANCE MATERIALS OPERATIONS LLC (US) | 2024-07-23 | — | — | US | disclosed |
| US-20230234917-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | SENDA BIOSCIENCES INC (US) | 2023-07-27 | — | — | US | disclosed |
| WO-2021252640-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | SENDA BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | WO | disclosed |
| CN-106661065-B | Crystal of cyclic phosphonic acid sodium salt and method for producing same | 大塚化学株式会社 | 2021-09-24 | — | — | CN | disclosed |
| US-20210246256-A1 | POLYURETHANE FOAM OR POLYETHER POLYOL STABILIZED WITH A BENZOFURANONE-PHOSPHITE DERIVATIVE | BASF SE (DE) | 2021-08-12 | — | — | US | disclosed |
| EP-3814396-A1 | POLYURETHANE FOAM OR POLYETHER POLYOL STABILIZED WITH A BENZOFURANONE-PHOSPHITE DERIVATIVE | BASF SE (DE) | 2021-05-05 | — | — | EP | disclosed |
| CN-112368313-A | Polyurethane foam or polyether polyol stabilized with benzofuranone-phosphite derivatives | 巴斯夫欧洲公司 | 2021-02-12 | — | — | CN | disclosed |
| WO-2020002130-A1 | POLYURETHANE FOAM OR POLYETHER POLYOL STABILIZED WITH A BENZOFURANONE-PHOSPHITE DERIVATIVE | BASF SE (DE) | 2020-01-02 | — | — | WO | disclosed |
| EP-1070692-B1 | METHODS FOR HIGHLY SELECTIVELY O-ALKYLATING AMIDE COMPOUNDS WITH THE USE OF COPPER SALTS | NIPPON SODA CO (JP) | 2004-05-19 | — | — | EP | disclosed |
| US-6462195-B1 | O-ALKYLATING A COMPOUND BY CONVERTING IT INTO THE COPPER SALT BY USING A MONOVALENT COPPER COMPOUND SUCH AS COPPER SUBOXIDE AND THEN REACTING IT WITH AN ALKYLATING AGENT HAVING A LEAVING GROUP IN THE PRESENCE OF A PHOSPHORUS COMPOUND | NIPPON SODA CO., LTD. (JP) | 2002-10-08 | — | — | US | disclosed |
| EP-1070692-A1 | METHODS FOR HIGHLY SELECTIVELY O-ALKYLATING AMIDE COMPOUNDS WITH THE USE OF COPPER SALTS | NIPPON SODA CO., LTD. (JP) | 2001-01-24 | — | — | EP | disclosed |
| EP-0267794-B1 | PROCESS FOR PREPARING POLYOLEFINS | Nippon Petrochemicals Co., Ltd. (JP) | 1993-05-05 | — | — | EP | disclosed |
| EP-0262202-B1 | METHOD FOR PREPARING PENICILLANIC ACID DERIVATIVES | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) | 1992-07-01 | — | — | EP | disclosed |
| EP-0267794-A2 | Process for preparing polyolefins | Nippon Petrochemicals Co., Ltd. (JP) | 1988-05-18 | — | — | EP | disclosed |
| US-4525555-A | TITANIUM COMPOUND SUPPORTED ON SOLID REACTION PRODUCT OF MAGNESIUM HALIDE, SILOXANES, ORGANIC COMPOUNDS | NIPPON OIL COMPANY, LIMITED (JP) | 1985-06-25 | — | — | US | disclosed |
| US-4135045-A | PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-16 | — | — | US | disclosed |
| US-4067903-A | Manufacture of arylamines | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
| US-4048415-A | TITANIUM-ALUMINUM COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234917-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | ASNS, SI, NARS1 | MAPK1 4235/4885ALDH1A1 1286/4885ALOX15 2305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.